Compare PASG & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PASG | PETZ |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | China |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 12.8M |
| IPO Year | 2020 | 2017 |
| Metric | PASG | PETZ |
|---|---|---|
| Price | $4.20 | $1.32 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | 25.7K | ★ 35.0K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.29 | $0.81 |
| 52 Week High | $20.00 | $1.83 |
| Indicator | PASG | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 47.52 |
| Support Level | $4.27 | $1.10 |
| Resistance Level | $4.95 | $1.40 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 18.51 | 16.67 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
TDH Holdings Inc currently focus on commercial real estate management. The company has determined that it has only one operating segment which is commercial real estate leasing operations. The company has presence in China and United States of which majority of revenue comes from China.